These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32918637)

  • 1. Risk factors of disease activity in patients with Behçet's syndrome.
    Hou CC; Guan JL
    Clin Rheumatol; 2021 Apr; 40(4):1465-1471. PubMed ID: 32918637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and risk factors of intestinal involvement in Behçet's syndrome patients: a cross-sectional study from a single center.
    Hou CC; Ye JF; Ma HF; Guan JL
    Orphanet J Rare Dis; 2021 Mar; 16(1):132. PubMed ID: 33731182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical heterogeneity of ocular Behçet's syndrome versus intestinal Behçet's syndrome: a cross-sectional study from Shanghai Behçet's syndrome database.
    Hou CC; Luo D; Bao HF; Ye JF; Ma HF; Shen Y; Zou J; Guan JL
    Arthritis Res Ther; 2022 Apr; 24(1):98. PubMed ID: 35488313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of infliximab refractory intestinal Behçet's syndrome: A retrospective cohort study from the Shanghai Behçet's syndrome database.
    Bao HF; Hou CC; Ye B; Zou J; Luo D; Cai JF; Shen Y; Guan JL
    Mod Rheumatol; 2023 Jan; 33(1):207-216. PubMed ID: 34932796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relation of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume with the presence and severity of Behçet's syndrome.
    Alan S; Tuna S; Türkoğlu EB
    Kaohsiung J Med Sci; 2015 Dec; 31(12):626-31. PubMed ID: 26709224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil/lymphocyte ratio and mean platelet volume in Behçet's disease.
    Balkarli A; Kucuk A; Babur H; Erbasan F
    Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3045-50. PubMed ID: 27460734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary case-control study to evaluate diagnostic values of C-reactive protein and erythrocyte sedimentation rate in differentiating active Crohn's disease from intestinal lymphoma, intestinal tuberculosis and Behcet's syndrome.
    Liu S; Ren J; Xia Q; Wu X; Han G; Ren H; Yan D; Wang G; Gu G; Li J
    Am J Med Sci; 2013 Dec; 346(6):467-72. PubMed ID: 23689052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between red blood cell distribution width and disease activity in patients with Behçet's disease.
    Aksoy ŞN; Savaş E; Sucu M; Kisacik B; Kul S; Zengin O
    J Int Med Res; 2015 Dec; 43(6):765-73. PubMed ID: 26359293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the arterial intima-media thickness in Behcet's disease patients without vascular complaints.
    Kankilic N; Aslan A; Karahan O; Demirtas S; Caliskan A; Yavuz C
    Vascular; 2018 Aug; 26(4):356-361. PubMed ID: 29182089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel markers of endothelial dysfunction and inflammation in Behçet's disease patients with ocular involvement: epicardial fat thickness, carotid intima media thickness, serum ADMA level, and neutrophil-to-lymphocyte ratio.
    Yuksel M; Yildiz A; Oylumlu M; Turkcu FM; Bilik MZ; Ekinci A; Elbey B; Tekbas E; Alan S
    Clin Rheumatol; 2016 Mar; 35(3):701-8. PubMed ID: 25744156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of tocilizumab in Behçet's syndrome with refractory arterial lesions: a single-centre observational cohort study in China.
    Zhong H; Liu T; Liu Y; Zhang X; Zhou Y; Su Y
    Rheumatology (Oxford); 2022 Jul; 61(7):2923-2930. PubMed ID: 34791076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discordance between patient and physician global assessment of disease activity in Behçet's syndrome: a multicenter study cohort.
    Floris A; Espinosa G; Serpa Pinto L; Kougkas N; Lo Monaco A; Lopalco G; Orlando I; Bertsias G; Cantarini L; Cervera R; Correia J; Govoni M; Iannone F; Mathieu A; Neri P; Martins Silva A; Vasconcelos C; Muntoni M; Cauli A; Piga M;
    Arthritis Res Ther; 2020 Nov; 22(1):278. PubMed ID: 33239083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein/albumin ratio as an indicator of disease activity in Behçet's disease and human leukocyte antigen-B27-associated uveitis.
    Kim M; Park YG; Park YH
    Graefes Arch Clin Exp Ophthalmol; 2021 Jul; 259(7):1985-1992. PubMed ID: 33929591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum anti-lysozyme is associated with disease activity of Behçet's disease.
    Park JS; Kang MI; Ha YJ; Song JJ; Park YB; Lee SK; Lee SW
    Int J Rheum Dis; 2017 Feb; 20(2):261-268. PubMed ID: 26890818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum PLR and LMR in Behçet's disease: Can they show the disease activity?
    Jiang Y; Zang M; Li S
    Medicine (Baltimore); 2017 May; 96(21):e6981. PubMed ID: 28538403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in Behçet's disease: which and when to use?
    Hammad M; Shehata OZ; Abdel-Latif SM; El-Din AMM
    Clin Rheumatol; 2018 Oct; 37(10):2811-2817. PubMed ID: 29980877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suicidal ideation among patients with Behçet's syndrome.
    Saygin C; Uzunaslan D; Hatemi G; Hamuryudan V
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S30-5. PubMed ID: 25797433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
    Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
    Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil-to-lymphocyte ratio, mean platelet volume and platelet-to-lymphocyte ratio in Behçet's disease and their correlation with disease activity: A meta-analysis.
    Lee YH; Song GG
    Int J Rheum Dis; 2018 Dec; 21(12):2180-2187. PubMed ID: 30417545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor prognostic factors in patients with newly diagnosed intestinal Adamantiades-Behçet's disease in the Shanghai Adamantiades-Behçet's disease database: a prospective cohort study.
    Zhang L; Tian Y; Ye JF; Lin CH; Guan JL
    Orphanet J Rare Dis; 2019 Nov; 14(1):274. PubMed ID: 31779646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.